ACTINIUM PHARMACEUTICALS INC (ATNM) Stock Cash Flow
NYSEARCA:ATNM - NYSE Arca - US00507W2061 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -40.91M | -48.82M | -33.02M | -24.77M | -22.21M | |||
| Depreciation Amortization | 806.00K | 790.00K | 699.00K | 524.00K | 447.00K | |||
| Change In Working Capital | 282.00K | -3.15M | 38.17M | 1.69M | -1.10M | |||
| Interest Paid | 0.00 | 0.00 | 0.00 | 0.00 | 8.00K | |||
| Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 5.02M | 3.84M | 2.79M | 1.69M | 1.25M | |||
| OPERATING CASH FLOW | -34.81M | -47.34M | 8.64M | -20.87M | -21.62M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -11.00K | -153.00K | -366.00K | -133.00K | -253.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | -11.00K | -153.00K | -366.00K | -133.00K | -253.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -8.00K | -4.00K | -49.00K | -85.00K | -460.00K | |||
| Stock Issued/Repurchased | 30.52M | 14.87M | 23.16M | 35.31M | 76.64M | |||
| FINANCING CASH FLOW | 30.52M | 14.87M | 23.11M | 35.22M | 76.18M | |||
| CHANGE IN CASH | -4.31M | -32.62M | 31.39M | 14.22M | 54.31M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -34.81M | -47.34M | 8.64M | -20.87M | -21.62M | |||
| Capital Expenditure | -11.00K | -153.00K | -366.00K | -133.00K | -253.00K | |||
| FREE CASH FLOW | -34.82M | -47.49M | 8.28M | -21.00M | -21.87M | |||
All data in USD